Results plateauing After initial improvements, some users find results level off
A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
Ingredient qualification, testing, documentation, and controls designed to provide confidence from raw material through finished product
This might include custom-compounded GHK-Cu topical foam, injectable peptide therapy, a heavy metal detoxification program, hormone optimization, or a combination of approaches